Headache in essential thrombocythaemia - Wikidata - awgldk - TriplyDB

Headache in essential thrombocythaemia

Headache in essential thrombocythaemia

http://www.wikidata.org/entity/Q24629739

about

Clinical Characteristics of Cerebrovascular Pathology with Patients Suffering from Ph-Negative Myeloproliferative Disease.Neurological symptoms in essential thrombocythemia: impact of JAK2V617F mutation and response to therapy.

P2860

Q37293639-5D40B168-4842-49E4-B6F0-0B946DE05AC2 Q41553988-807EAFCC-48A9-4A77-942B-0897C48E311E

P2860

Headache in essential thrombocythaemia

http://www.wikidata.org/entity/Q24629739

description

2012 nî lūn-bûn

@nan

2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Headache in essential thrombocythaemia

@ast

Headache in essential thrombocythaemia

@en

Headache in essential thrombocythaemia

@nl

type

label

Headache in essential thrombocythaemia

@ast

Headache in essential thrombocythaemia

@en

Headache in essential thrombocythaemia

@nl

prefLabel

Headache in essential thrombocythaemia

@ast

Headache in essential thrombocythaemia

@en

Headache in essential thrombocythaemia

@nl

P1433

Q24629739-C6156B2D-DC74-4497-866D-57004EF2716E

P1476

Q24629739-0EDE7C31-ACD0-4DCF-81B3-FAF1BA588000

P2093

Q24629739-4E02940A-58BF-4D03-94FE-BFE16E25691D

Q24629739-EB9902E7-F40C-480A-8D1D-78856638514F

P275

Q24629739-8B6038BD-DFF8-46B0-A53D-4F0C54863BB6

P2860

Q24629739-055DD58A-C0D7-490C-AED6-87251C69AA3F

Q24629739-0E002C43-4D7C-4693-BCC9-074F883FD198

Q24629739-1364187F-64B6-4D23-A1A9-B7557E70147E

Q24629739-1A2E26AF-4C23-4E54-9939-0D1D45E9CEE1

Q24629739-1E4A9AD0-1677-4FC0-AA92-372EA3303A3E

Q24629739-2199B5D3-93A7-4B34-B9B9-5AC4962D138A

Q24629739-23065183-1289-4C83-9846-9E71904BC2BA

Q24629739-29E1EB7F-D6D6-497A-9938-9B43E5397615

Q24629739-2E40D590-9449-4173-9FBB-020D421F4D56

Q24629739-35F038D6-8E89-4568-9A75-F4FAEC043D1E

P304

Q24629739-FFEEF4F6-B00B-49AB-AB01-9ECBF713ABF6

P31

Q24629739-025F070C-7FB6-4F42-BBD9-D51021D1F3D7

Q24629739-6904877C-2C03-4490-9E1E-4CF2C2AB7072

P3181

Q24629739-642E92F2-57E2-4590-8C0D-D5B11B64BB17

P356

Q24629739-0FDE50F7-C9E1-40C4-8742-8B9C7DE455F8

P407

Q24629739-C2D8DA68-8110-45AA-B843-E86F171E2FD5

P433

Q24629739-D622FE43-6FE8-4F4C-9D2A-7B9625905689

P478

Q24629739-C9770593-BD79-4366-A2B8-A56539B5B1F5

P5008

Q24629739-FCC673D3-0289-443D-AFED-60334EE8AFDA

P577

Q24629739-A5859E7A-0ECB-42E5-A688-8422AE48F972

Q24629739-E9FFCE29-F3DB-4423-8A6B-16475535B650

P5875

Q24629739-0D0ED936-DC3C-44BD-9759-8CBE00F08BA5

P698

Q24629739-ACB01726-28E4-4B94-B23B-A29611BCD54A

P921

Q24629739-247AA58C-7480-40E2-84BE-CE0A7F2A3C80

Q24629739-4A324021-C8EF-4D32-B7A1-CD05389011A1

P932

Q24629739-EAD50516-0378-47D3-913C-1D5FBA10ABB9

P3181

P356

J.1742-1241.2012.02986.X

P1433

International Journal of Clinical Practice

P1476

Headache in essential thrombocythaemia

@en

P2093

A Dowson

http://www.w3.org/2001/XMLSchema#string

R Frewin

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 2.5 Unported

P2860

Anagrelide for thrombocytosis in myeloproliferative disorders: a prospective study to assess efficacy and adverse event profile

Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia

Platelet-mediated microvascular inflammation and thrombosis in thrombocythemia vera: a distinct aspirin-responsive arterial thrombophilia, which transforms into a bleeding diathesis at increasing platelet counts

Acute leukemia in polycythemia vera: an analysis of 1638 patients enrolled in a prospective observational study

Guideline for investigation and management of adults and children presenting with a thrombocytosis

The International Classification of Headache Disorders: 2nd edition

Long-term use of anagrelide in young patients with essential thrombocythemia.

Adverse effects and benefits of two years of anagrelide treatment for thrombocythemia in chronic myeloproliferative disorders.

Anagrelide: a new drug for treating thrombocytosis.

Aspects on the pathophysiology of migraine and cluster headache.

P304

976-83

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3651149

http://www.w3.org/2001/XMLSchema#string

P356

10.1111/J.1742-1241.2012.02986.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

66

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2012-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230664690

http://www.w3.org/2001/XMLSchema#string

P698

22889110

http://www.w3.org/2001/XMLSchema#string

P921

Essential thrombocytosis

P932

3469735

http://www.w3.org/2001/XMLSchema#string